TRACY LAKIN: Open Payments
NPI 1821474446 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 19 payments from 9 companies in 2025. Trend: 2023 $695 · 2024 $399 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $163 |
| Pulmonx Corporation | 1 | $150 |
| Amgen Inc. | 1 | $139 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $123 |
| Biosense Webster, Inc. | 7 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $14 |
Products named: CHARTIS CATHETER, CAMZYOS, REXULTI, Wegovy, CARTO 3, LEQVIO, ELIQUIS, LifeVest.
Industry payments across AL — which companies pay providers there.
